Showing results (2091-2100 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factorP Ragnhammar, G Masucci, J E Frödin, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic miceE Hurwitz, R Adler, D Shouval, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cellsF Vánky, P Wang, E Klein
Cancer Immunology, Immunotherapy : CII|January 1, 1992
A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2aR Handgretinger, P Baader, R Dopfer, et al.
Cancer Immunology, Immunotherapy : CII|November 26, 1998
Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-alphaM Hoffmann, M Schmidt, W Wels
Cancer Immunology, Immunotherapy : CII|November 26, 1998
The effect of recombinant human granulocyte/macrophage-colony-stimulating factor (rHu GM-CSF) and rHu G-CSF administration on neutrophil chemiluminescence assay in patients following cyclic chemotherapyM Aslan, G Yucel, H Bozcuk, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1996
Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2M J Ehrke, S Verstovsek, G Zaleskis, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1996
Identification of peptide epitopes of MAGE-1, -2, -3 that demonstrate HLA-A3-specific bindingC A McIntyre, R C Rees, K E Platts, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Increased efficiency of immunotherapy using irradiated tumor cellsJ M Wu, J Fitzgerald, S Sonis, et al.
Pageof 652